Archrock, Inc. Files 8-K: Regulation FD & Exhibits
Ticker: AROC · Form: 8-K · Filed: Aug 27, 2024 · CIK: 1389050
| Field | Detail |
|---|---|
| Company | Archrock, INC. (AROC) |
| Form Type | 8-K |
| Filed Date | Aug 27, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.01 |
| Sentiment | neutral |
Sentiment: neutral
Topics: disclosure, regulatory
TL;DR
Archrock filed an 8-K for standard disclosures. Check exhibits for details.
AI Summary
Archrock, Inc. filed an 8-K on August 27, 2024, to report a Regulation FD Disclosure and Financial Statements and Exhibits. The filing does not contain specific financial figures or new material events beyond the standard reporting requirements.
Why It Matters
This filing indicates Archrock, Inc. is fulfilling its regulatory disclosure obligations. Investors should review the exhibits for any potentially material information not explicitly detailed in the summary.
Risk Assessment
Risk Level: low — The filing is a routine 8-K for disclosures and exhibits, not indicating any new material events or risks.
Key Players & Entities
- Archrock, Inc. (company) — Registrant
- August 27, 2024 (date) — Date of Report
- 001-33666 (other) — Commission File Number
- 74-3204509 (other) — I.R.S. Employer Identification No.
- 9807 Katy Freeway , Suite 100 , Houston , TX 77024 (address) — Principal executive offices
- 281-836-8000 (phone_number) — Registrant's telephone number
FAQ
What is the primary purpose of this 8-K filing for Archrock, Inc.?
The primary purpose of this 8-K filing is to report a Regulation FD Disclosure and to provide Financial Statements and Exhibits.
On what date was this 8-K report filed?
The report was filed on August 27, 2024.
What is Archrock, Inc.'s Commission File Number?
Archrock, Inc.'s Commission File Number is 001-33666.
Where are Archrock, Inc.'s principal executive offices located?
Archrock, Inc.'s principal executive offices are located at 9807 Katy Freeway, Suite 100, Houston, TX 77024.
Does this filing announce any specific new business developments or financial results?
This filing primarily serves as a notification for Regulation FD Disclosure and the submission of Financial Statements and Exhibits, and does not explicitly detail new business developments or specific financial results within the provided text.
Filing Stats: 549 words · 2 min read · ~2 pages · Grade level 10.4 · Accepted 2024-08-27 07:58:47
Key Financial Figures
- $0.01 — ch registered Common stock, par value $0.01 per share AROC New York Stock Excha
Filing Documents
- tm2422758d1_8k.htm (8-K) — 24KB
- tm2422758d1_ex99-1.htm (EX-99.1) — 8KB
- tm2422758d1_ex99-1img001.jpg (GRAPHIC) — 98KB
- 0001104659-24-093085.txt ( ) — 339KB
- aroc-20240827.xsd (EX-101.SCH) — 3KB
- aroc-20240827_lab.xml (EX-101.LAB) — 33KB
- aroc-20240827_pre.xml (EX-101.PRE) — 22KB
- tm2422758d1_8k_htm.xml (XML) — 4KB
01
Item 7.01 Regulation FD Disclosure. On August 27, 2024, Archrock, Inc. (the "Company") issued a press release announcing the expiration of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended, with respect to the Company's pending acquisition of all the issued and outstanding equity interests in Total Operations and Production Services, LLC ("TOPS"), a portfolio company managed by certain affiliates of Apollo Global Management, Inc. A copy of the press release is furnished herewith as Exhibit 99.1 and is incorporated herein by reference. The information included in this Item 7.01 and Exhibit 99.1 attached hereto is being furnished and shall not be deemed "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section. The information included in this Item 7.01 and Exhibit 99.1 attached hereto shall not be incorporated by reference into any registration statement or other document pursuant to the Securities Act of 1933, as amended.
Financial Statements and Exhibits
Financial Statements and Exhibits. (d) Exhibits . Exhibit Number Description 99.1 Archrock, Inc. press release, dated August 27, 2024, announcing the expiration of the Hart-Scott-Rodino Act waiting period. 104 Cover Page Interactive Data File (embedded within the Inline XBRL document). 2 SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. ARCHROCK, INC. /s/ Stephanie C. Hildebrandt Stephanie C. Hildebrandt Senior Vice President, General Counsel and Secretary Date: August 27, 2024 3